Analysen von Jo Walton
05.03.24 | Novo Nordisk Neutral | UBS AG | |
05.03.24 | Bayer Neutral | UBS AG | |
27.02.24 | Novo Nordisk Neutral | UBS AG | |
20.02.24 | Bayer Neutral | UBS AG | |
05.02.24 | Novo Nordisk Neutral | UBS AG | |
02.02.24 | Novo Nordisk Neutral | UBS AG | |
31.01.24 | Novo Nordisk Neutral | UBS AG | |
30.01.24 | Novo Nordisk Neutral | UBS AG | |
Werbung
|
|||
29.01.24 | Bayer Neutral | UBS AG | |
18.01.24 | Bayer Neutral | UBS AG | |
15.01.24 | Novo Nordisk Neutral | UBS AG | |
08.01.24 | Bayer Neutral | UBS AG | |
19.12.23 | Bayer Neutral | UBS AG | |
04.12.23 | Bayer Neutral | UBS AG | |
31.10.22 | Bayer Neutral | Credit Suisse Group | |
12.10.22 | GSK Neutral | Credit Suisse Group | |
11.05.22 | Bayer Neutral | Credit Suisse Group | |
10.11.21 | Bayer Neutral | Credit Suisse Group | |
06.08.21 | Bayer Neutral | Credit Suisse Group | |
22.07.21 | Novartis Neutral | Credit Suisse Group | |
02.05.19 | GSK Neutral | Credit Suisse Group | |
10.04.19 | GSK Neutral | Credit Suisse Group | |
17.12.18 | GSK Neutral | Credit Suisse Group |